Passionate and highly motivated professional with more than 15 years’ post-graduate experience in immunology, oncology, gene therapy and neuroscience. Extensively skilled in experimental design and development, guiding and mentoring, trouble shooting, data analyzing and managing multiple priorities. Willingness to take on added responsibilities to meet team goals with a high degree of accuracy. Dedicated to help team to achieve company goals, improving efficiency and effectiveness, identifying and reducing expenses to make high quality products be accessible and affordable for everybody.
• 2023-04
Surguchov, A.; Emamzadeh, F.N.; Titova, M.; Surguchev, A.A. Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era. Biomedicines 2023, 11, 1215. https://doi.org/10.3390/biomedicines11041215
• 2020-07
Emamzadeh F. N, Word B, Cotton E, et al. Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro. Anticancer Res. 2020;40(7):3669-3683. doi:10.21873/anticanres.14356
• 2019-06
Surguchov A, Emamzadeh F. N, Surguchev AA. Amyloidosis and Longevity: A Lesson from Plants. Biology 8: 43.
• 2019-01
Surguchev AA, Emamzadeh F. N, Surguchov A. Cell Responses to Extracellular α- Synuclein. Molecules. 24: 305.
• 2018-08
Emamzadeh, F. N, & Surguchov, A. Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors. Frontiers in Neuroscience. 12: 612.
• 2017-07
Emamzadeh, F.N. Role of Apolipoproteins and α-Syn in Parkinson’s Disease. J Mol Neuro. 62: 344.
• 2017-09
Emamzadeh, F.N & Allsop, D.α-Synuclein interacts with lipoproteins in plasma. J Mol Neurosci. 63: 165.
· 2017-10
Emamzadeh F.N. A Multipurpose Preclinical and Clinical Diagnostic Tool. Journal of Biomedical Science & Applications. Vol. 1 No. 1:4.
• 2016-05
Emamzadeh F.N. Alpha-synuclein structure, functions, and interactions. J Res Med Sci. 21: 29.
• 2016-08
Emamzadeh, F.N, Aojula H, McHugh PC, Allsop D. Effects of different isoforms of apoE on aggregation of the α ‐synuclein protein implicated in Parkinson’s disease. Neuroscience Lett. 618: 146-151.
• 2016-06
Hojati Z, Emamzadeh F.N, Dehghanian F. Association between polymorphisms of exon 12 and exon 24 of JHDM2A gene and male.
Dr. Beverly Lyn-Cook, FDA
Senior Interdisciplinary Research Biologist
E-mail: Beverly.lyn-cook@fda.hhs.gov
Phone Number: 870 543 7965
Dr. George Hammons, FDA
E-mail: George.Hammons@fda.hhs.gov
Phone Number: 870 543 7121
Ms. Beverly Word, FDA
E-mail: Beverly.word@fda.hhs.gov
Phone Number: 870 543 7968
Dr. Takashi Kasi,
MD at Kyoto Prefectural University, Japan
E-mail: kasaita@koto.kpu-m.ac.jp
Phone Number: +81 75 366 8328